Migraines do not improve, but health care utilization decreases following GLP-1 initiation

Patients with migraine who began using GLP-1 receptor agonists for obesity did not experience any significant changes in headache outcomes, according to data presented at the American Headache Society 68th Annual Scientific Meeting.However, initiation of these drugs was associated with less health care utilization and treatment escalation compared with topiramate, Scott Yuan, MD, PhD, director,